NTV Asset Management LLC Purchases Shares of 476 Intuitive Surgical, Inc. (NASDAQ:ISRG)

NTV Asset Management LLC bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 476 shares of the medical equipment provider's stock, valued at approximately $236,000.

Several other hedge funds also recently bought and sold shares of ISRG. Norges Bank bought a new position in Intuitive Surgical in the 4th quarter worth $2,401,493,000. GAMMA Investing LLC raised its position in shares of Intuitive Surgical by 54,010.7% during the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after buying an additional 3,022,979 shares in the last quarter. Capital Research Global Investors raised its position in shares of Intuitive Surgical by 25.5% during the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after buying an additional 687,906 shares in the last quarter. Northern Trust Corp raised its position in shares of Intuitive Surgical by 15.8% during the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock valued at $1,889,126,000 after buying an additional 494,496 shares in the last quarter. Finally, Vanguard Group Inc. raised its position in Intuitive Surgical by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after purchasing an additional 360,591 shares during the period. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Price Performance

ISRG traded down $0.70 on Thursday, reaching $527.43. 470,340 shares of the company's stock were exchanged, compared to its average volume of 1,669,375. The stock's fifty day moving average price is $538.02 and its 200-day moving average price is $536.87. Intuitive Surgical, Inc. has a twelve month low of $413.82 and a twelve month high of $616.00. The stock has a market cap of $189.04 billion, a PE ratio of 77.30, a P/E/G ratio of 5.59 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same period in the prior year, the firm earned $1.50 earnings per share. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have recently commented on ISRG shares. Royal Bank Of Canada reduced their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Barclays dropped their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Deutsche Bank Aktiengesellschaft downgraded shares of Intuitive Surgical from a "hold" rating to a "sell" rating and dropped their price objective for the company from $515.00 to $440.00 in a research note on Monday, June 9th. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Thursday, June 5th. Finally, BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $592.59.

Insider Activity

In other Intuitive Surgical news, SVP Mark Brosius sold 216 shares of the stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president directly owned 907 shares of the company's stock, valued at approximately $510,740.77. This represents a 19.23% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Gary Loeb sold 1,700 shares of the firm's stock in a transaction that occurred on Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the transaction, the executive vice president owned 2,245 shares in the company, valued at $1,152,089.10. This represents a 43.09% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.